These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5897831)

  • 41. Estradiol and progersterone receptors in F1 (C3H X RIII) mice mammary tumors: effect of castration.
    Edery M; Drosdowsky MA
    Biomedicine; 1980 May; 33(3):80-2. PubMed ID: 7448327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experimental study of antitumor activity of the antibiotic bruneomycin].
    Shorin VA; Rossolimo OK; Stanislavskaia MS; Pevzner NS; Shapovalova SP; Lepeshkina GN
    Antibiotiki; 1966 Aug; 11(8):683-91. PubMed ID: 6014957
    [No Abstract]   [Full Text] [Related]  

  • 43. [Estrogen dependence of mammary gland tumors: the mechanisms of the disorder and the evaluation criteria].
    Merkulova TI; Morozova TM; Sakganik RI
    Vopr Onkol; 1980; 26(10):67-75. PubMed ID: 7434681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hormonal therapy of the advanced breast cancer ].
    Gürtler R; Matthes ML; Tanneberger S
    Arch Geschwulstforsch; 1982 May; 52(3):231-40. PubMed ID: 7125859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.
    Janssens JP; Billiet G; Bonte J; De Loecker W
    Anticancer Res; 1983; 3(6):385-91. PubMed ID: 6230984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoplasms evoked in male Sprague-Dawley rat by pulse doses of 7,12-dimethylbenz(a)anthracene.
    Huggins CB; Grand L
    Cancer Res; 1966 Nov; 26(11):2255-8. PubMed ID: 5956630
    [No Abstract]   [Full Text] [Related]  

  • 47. Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and their hormonal control.
    Asselin J; Melançon R; Moachon G; Bélanger A
    Cancer Res; 1980 May; 40(5):1612-22. PubMed ID: 6768450
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparative study of the anti-inflammatory, analgesic and antipyretic actions of antitumor preparations].
    Trinus FP; Chernov VA; Riabukha TK; Sharykina NI
    Vopr Onkol; 1980; 26(5):49-54. PubMed ID: 6966858
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of prepubertal ovariectomy on survival and specific diseases in female RFM mice given 300 R of x rays.
    Holland JM; Mitchell TJ; Walburg HE
    Radiat Res; 1977 Feb; 69(2):317-27. PubMed ID: 576501
    [No Abstract]   [Full Text] [Related]  

  • 50. Combination therapy of 3-methylcholanthrene-induced mammary carcinoma in rats: effect of chemotherapy, ovariectomy, and food restriction.
    Gropper L; Shimkin MB
    Cancer Res; 1967 Jan; 27(1):26-32. PubMed ID: 6071371
    [No Abstract]   [Full Text] [Related]  

  • 51. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of adaptogens on the growth and metastasis of Pliss lymphosarcoma during laparotomy].
    Moskalik KG
    Vopr Onkol; 1970; 16(7):74-8. PubMed ID: 5536602
    [No Abstract]   [Full Text] [Related]  

  • 53. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4).
    Matsuzawa A; Mizuno Y; Yamamoto T
    Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hematopoietic resistance to the damaging action of cytostatics in the occurrence of tumor drug resistance].
    Rakhimov KD; Vermenichev SM; Kabiev OK
    Vopr Onkol; 1981; 27(7):57-61. PubMed ID: 6894988
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of amethopterin on cells of experimental tumors.
    Lin H; Bruce WR
    Ann N Y Acad Sci; 1971 Nov; 186():325-9. PubMed ID: 5289424
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of malignant tumors with various characteristics on the state of the estradiol receptor system in peripheral target organs].
    Savinskaia AP; Boguslavskaia EV
    Biull Eksp Biol Med; 1984 Jan; 97(1):79-81. PubMed ID: 6546352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental chemotherapy of heterotransplanted Hodgkin- and non-Hodgkin-lymphoma cell lines in nude mice.
    Kirchner HH; Engert A; Diehl V
    Behring Inst Mitt; 1984 May; (74):329-36. PubMed ID: 6477360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proliferative responses of mouse mammary glands to 17 beta-estradiol and progesterone and modification by mouse mammary tumor virus.
    Lee AE
    J Natl Cancer Inst; 1983 Dec; 71(6):1265-9. PubMed ID: 6317935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induced mammary carcinoma in the female rat as a drug evaluation system.
    Griswold DP; Skipper HE; Laster WR; Wilcox WS; Schabel FM
    Cancer Res; 1966 Oct; 26(10):2169-80. PubMed ID: 5921488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.